Efficacy and tolerability of abatacept treatment: results of 12 months observation von Borisova, M A, Lukina, G V, Sigidin, Y A, Aronova, E S, Luchihina, E L, Karateev, D E, Glukhova, S V, Nasonov, E L

Volltext

THU0122 Multi-Biomarker Scores as Predictors of Response to Biologic Therapies in Rheumatoid Arthritis von Novikov, A., Alexandrova, E. N., Gerasimov, A. N., Avdeeva, A. S., Lukina, G. V., Sigidin, Y. A., Popkova, T. V., Panasyuk, E. Y., Nasonov, E. L.

Volltext

Infliximab in the therapy of rheumatoid arthritis von Lukina, G. V., Sigidin, Y. A., Posdnyakova, E. S., Luchihina, E. L., Karateev, D. E., Nasonov, E. L.

Volltext

Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis von Sigidin, Y A, Loukina, G V, Skurkovich, B, Skurkovich, S

Volltext

Tyrosine kinase inhibitor Tofacitinib. Safety issues von G. V. Lukina, Y. A. Sigidin

Volltext

A10.09 Safety data of four treatment regimens in early rheumatoid arthritis patients von Fedorenko, EV, Lukina, GV, Sigidin, YA

Volltext

A4.9Effect of different doses of Rituximab on the progression of bone destruction in rheumatoid arthritis (RA) von Pivanova, A V, Lukina, G V, Sigidin, YA, Smirnov, A V, Kuzikyants, KH, Kuznetsova, A Y, Nasonov, EL

Volltext

A4.9 Effect of different doses of Rituximab on the progression of bone destruction in rheumatoid arthritis (RA) von Pivanova, AV, Lukina, GV, Sigidin, YA, Smirnov, AV, Kuzikyants, KH, Kuznetsova, AY, Nasonov, EL

Volltext

A8.11Efficacy and safety of abatacept in patients with early and long-standing rheumatoid arthritis von Kanonirova, MA, Lukina, G V, Sigidin, YA, Aronova, E S, Luchihina, EL, Karateev, DE, Nasonov, EL

Volltext

A8.11 Efficacy and safety of abatacept in patients with early and long-standing rheumatoid arthritis von Kanonirova, MA, Lukina, GV, Sigidin, YA, Aronova, ES, Luchihina, EL, Karateev, DE, Nasonov, EL

Volltext

AB0465 Comparison of Abatacept Efficacy and Safety in Different Stages Rheumatoid Arthritis von Maria, K.A., Lukina, G.V., Sigidin, Y.A., Aronova, E.S., Glukhova, S.I., Luchihina, E.L., Karateev, D.E., Nasonov, E.L.

Volltext

A7.10 Results of abatacept treatment in patients with different duration of rheumatoid arthritis von Kanonirova, MA, Lukina, GV, Sigidin, YA, Aronova, ES, Glukhova, SI, Luchihina, EL, Karateev, DE, Nasonov, EL

Volltext

CHONDROPROTECTIVE DRUG ALFLUTOP IN THE TREATMENT OF OSTEOARTHRITIS von Lukina, G V, Sigidin, Y A

Volltext

A new direction in the treatment of rheumatoid arthritis: anti-B cell therapy von Lukina, G V, Sigidin, Y A

Volltext

Safety of treatment with adalimumab von Lukina, G. V., Sigidin, Y A

Volltext

Adalimumab in the treatment of early rheumatoid arthritis von Sigidin, Y A, Lukina, G. V.

Volltext

Felty syndrome and large granular leukocyte T-cell leukemia — a natural combination von Sigidin, Y A, Lukina, G V, Posdnyakova, E S

Volltext

Comparative efficacy of modern methods of treatment of early rheumatoid arthritis (preliminary results) von Fedorenko, E. V., Lukina, G. V., Sigidin, Y A, Karateev, D. E., Nasonov, E L

Volltext

A new direction in the treatment of rheumatoid arthritis: anti-B cell therapy von G V Lukina, Y A Sigidin

Volltext

Long-term experience of alflutop administration in clinical practic von Lukina, G. V., Sigidin, Y A, Denisov, L N

Volltext